Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat versus epoetin sequence study in dialysis-related renal anemia
ChiCTR2100051775Phase 4Recruiting
- Sponsor
- Nanjing Medical University Fourth Affiliated Hospital
- Start
- Oct 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of roxadustat and Epoetin alfa RB in Uraemic Anaemia (2 arms), sponsored by Nanjing Medical University Fourth Affiliated Hospital. Primary endpoints: Hepcidin, Fibroblast growth factor 23 and 1 more. Started Oct 2021; status: recruiting.
02
Drugs
roxadustatEpoetin alfa RB
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on ChiCTR2100051775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051775.